Sign In
Buy ACHV
$4.92
-0.110 (-2.19%)
At Close: Jun 03, 2026
Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript
03:14pm, Tuesday, 24'th Mar 2026
Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript
San Diego, California--(Newsfile Corp. - March 24, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Achieve Life Sciences, Inc. (NASDAQ: ACHV). The investigatio
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
07:00am, Tuesday, 24'th Mar 2026
Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, Br
SEATTLE and VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average – Time to Sell?
03:02am, Friday, 13'th Mar 2026
Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) shares passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $4.24 and traded as hi
A pooled Phase 3 analysis of more than 1,600 people who smoke showed high quit rates; including among those who had previously not succeeded with other smoking cessation medications and regardless of
Achieve Life Sciences (ACHV) Expected to Announce Earnings on Tuesday
03:07am, Tuesday, 03'rd Mar 2026
Achieve Life Sciences (NASDAQ: ACHV - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Tuesday, March 10th. Analysts expect the company to announce earnings of
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average – What’s Next?
04:56am, Wednesday, 25'th Feb 2026
Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $4.11 and traded as high as $
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of “Moderate Buy” by Brokerages
04:31am, Sunday, 08'th Feb 2026
Shares of Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five analysts that are presently covering the company, Marketbea
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch
08:57pm, Wednesday, 04'th Feb 2026
Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA. Cytisinicline's α4β2 partial agonism aims to reduce cravings and blunt ni
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
02:43am, Wednesday, 04'th Feb 2026
Achieve Life Sciences is a late-stage Pharma company awaiting FDA approval for Cytisinicline, a novel (though proven) smoking cessation therapy, with a decision expected in June. Cytisinicline demonst
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
04:05pm, Friday, 30'th Jan 2026
SEATTLE and VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development a
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
08:47am, Monday, 12'th Jan 2026
SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development a
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average – Here’s Why
03:34am, Wednesday, 07'th Jan 2026
Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving Average – Time to Sell?
03:28am, Saturday, 20'th Dec 2025
Shares of Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $3.4
